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ORIGINAL ARTICLE
Measuring process indicators and adverse events to assess the quality of care
for inpatients with psychosis
Jentien M. Vermeulena, Geeske van Rooijena, Mirjam J. van Trichta, Monique van Dijkb and Lieuwe de Haana
aDepartment of Psychiatry, Amsterdam UMC, Academic Medical Center, Amsterdam, The Netherlands; bDepartment of Internal Medicine,
Erasmus Medical Center, Rotterdam, The Netherlands
ABSTRACT
Background: Research into the quality of care in psychiatry is scarce. Data collection is falling behind
that for other fields of medicine and therefore the opportunity to improve care is missed.
Aims: In this medical record study we aim to determine: (i) whether or not patients’ physical health
indicators are assessed and pharmacological and behavioural treatment interventions applied; (ii) the
incidence and nature of adverse events in psychotic inpatients.
Methods: Medical records of inpatients with psychosis admitted to psychiatric wards at Amsterdam
UMC, location AMC, Department of psychiatry, were screened with a previously developed and tested
two-step patient safety tool.
Results: Data of 299 admissions were included. Physical health indicators were not assessed in one-
third of cases. Fifty-five percent of the patients were smokers but only 1% received an intervention.
The family was actively involved in 43% of the cases. During 11,403 admission days, 235 adverse
events had been recorded. The most frequent adverse event was adverse drug reactions (40%), which
were mostly related to antipsychotic medication.
Conclusions: In conclusion, quality of care auditing is useful to prioritize areas that need improve-
ment. Future research should focus on interventions to improve the quality of psychiatric care.
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Introduction
The importance of quality and safety of health care is firmly
established since 2000 by the reports “Crossing the quality
Chasm: A new health system for the 21st century” and “To
Err is Human” (Kohn, Corrigan, & Donaldson, 1999;
Medicine, 2001). Both reports highlight six key elements of
high-quality care: safe, effective, timely, efficient, equitable
and patient-centred. Still, the impact of that message in
psychiatry is very limited. The poor data infrastructure to
measure quality of care in psychiatry might be one of the
explanations for this backlog (Kilbourne et al., 2018; Pincus
et al., 2007). Consequently, improvement opportunities are
often missed (Kilbourne et al., 2018; Pincus, Spaeth-Rublee,
& Watkins, 2011). The first important step to identify areas
for improvement of care is an accurate measurement of
quality of care (Kohn et al., 1999; Nath & Marcus, 2006).
Particularly the dramatic mortality rates among patients
with psychosis – mainly caused by cardiovascular disease –
warrant greater attention (Olfson, Gerhard, Huang, Crystal,
& Stroup, 2015). Patients with a psychotic disorder live up
to 15 years shorter than the general population (Laursen,
Munk-Olsen, & Vestergaard, 2012; Olfson et al., 2015).
Quality of care is a complex construct. The most fre-
quently used framework to categorize the various measures
is the Donabedian Framework, which describes quality indi-
cators in the categories “structure”, “process” and “outcome”
(Figure 1). The structure indicators reflect mostly organiza-
tional factors used to compare health care facilities on a sys-
tem level (e.g. nursing-to-bed ratio). The process indicators,
on the other hand, refer to what was done for or to the
patient to improve his/her health and can be measured by
the rate of physical assessments and evidence-based treat-
ments such as antipsychotic medication or psychotherapy.
Lastly, the outcome measures reflect the actual patient out-
comes, for example, the level of improvement after treat-
ment or unwanted outcomes such as premature death.
Process indicators have been studied in a large sample of
schizophrenia patients from the United Kingdom (Crawford
et al., 2014). The researchers concluded that assessment of
risk factors, such as weight and blood pressure, as well as
treatment rates of these risk factors were far below standard
(Crawford et al., 2014). Although process indicators provide
a good picture of what was done for or to a patient, a
broader scope is needed to oversee the actual outcome, for
instance by combining process and outcome measures of
inpatient care (McGrath & Tempier, 2003). An internation-
ally recognized outcome indicator is the occurrence of
adverse events (AEs) – AEs are defined as the negative
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unintended consequences of clinical care that led to injury,
impairment, or other harm (Griffin & Resar, 2009; Kizer &
Stegun, 2005). A previous safety study reported that severely
mentally ill patients admitted to medical-surgical wards
experienced a mean number of almost six AEs per hospital-
ization (Daumit et al., 2016). A first study into safety of
hospitalized psychiatric patients reported that approximately
one in five patients experienced a patient safety event (AEs
or medical errors) (Marcus, Hermann, Frankel, & Cullen,
2017). To our knowledge, a study evaluating process and
outcome indicators of psychiatric inpatient care for patients
with psychosis is lacking.
We undertook a study to gain insight into the quality of
care provided to psychotic patients admitted to psychiatric
wards in Amsterdam UMC, location AMC, by combining
different indicators to assess processes and outcomes in
order to identify areas that need improvement. Specifically,
we aimed at answering the following questions: (i) to what
extent are physical health risk and status assessed and are
pharmacological and behavioural treatment interventions
applied (e.g. process indicators); (ii) what adverse events
occur and what are their incidences; and (iii) what clinical
characteristics are associated with adverse events (i.e. out-
come indicators).
Methods
Setting and study sample
In this retrospective study, we included data of patients with
a psychotic disorder discharged from three psychiatric wards
of the academic hospital Amsterdam UMC, location AMC,
Department of Psychiatry between January 2014 and
October 2015; i.e. a high care unit, a medium care unit, and
an early psychosis unit. Our catchment area covers an urban
population in The Netherlands.
Patients were offered a multidisciplinary treatment pro-
gram during admission (based on national guidelines (van
Alphen et al., 2012)) that matches the illness phase, e.g. first
episode or chronic. During treatment and depending on the
progress, patients gained more autonomy and were stimu-
lated to transfer from the high care unit to the medium care
unit or early psychosis unit as quickly as possible. The treat-
ment program consisted of a diagnostic phase and pharmaco-
logically focused treatment by medical doctors and
behavioural focused treatment by nurses, psychologists,
movement therapists, occupational therapists, and social
workers. The main goal of this program was to promote
recovery in such a way that transfer to an ambulatory (home
setting) was possible again. Alcohol drinking, cannabis use
and the use of other drugs are prohibited during admission
to our hospital. Smoking was allowed, however, inside three
smoking areas in the building or in the garden of the wards.
Inclusion was restricted to patients diagnosed within the
psychotic spectrum or bipolar I disorder with psychotic fea-
tures, according to the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition, 2000. This study has been
submitted to the Medical Ethics Committee of Amsterdam
UMC and was granted exemption of the Medical Research
Involving Human Subjects Act (WMO, 1992). The Dutch
Medical Research (Human Subjects) Act states that formal
ethical approval is necessary when the study meets both cri-
teria: (1) It concerns medical/scientific research; and (2)
Participants are subject to procedures or are required to fol-
low rules of behaviour (WMO, 1992). A medical record
study does not fall under these last criteria and, therefore,
the Medical Ethics Review Board of our institution decided
that formal approval was not necessary (see Supplementary
material). Besides, the data was used for quality improve-
ment projects. Together, this implies that participants do
not have to give consent to use their data anonymously in
research and formal approval was not asked. All procedures
performed in studies involving human participants were in
accordance with the ethical standards of the institutional
and/or national research committee and with the 1964
Helsinki declaration and its later amendments or compar-
able ethical standards. Anonymized data were used for ana-
lysis and reporting.
Definitions and procedure
Process indicators
Process indicators were selected based on a national audit
program for schizophrenia in the United Kingdom
(Crawford et al., 2014). These indicators are originally
extracted from the NICE guidelines on schizophrenia
(NICE, 2009) and therefore we selected only those which
are also applicable according to the local multidisciplinary
Schizophrenia Guidelines (van Alphen et al., 2012). A test
or intervention was assumed not to have taken place if it
was not documented (Crawford et al., 2014). The local
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Figure 1. Quality indicators as assessed in current study (with the exception of
structure indicators) based upon the Donabedian Framework.
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guidelines dictate that each patient should be offered a basic
somatic screening at intake. The percentage of patients not
screened might thus reflect refusal or failure to offer screen-
ing. The following process indicators were determined: (i)
Physical health risk factors: anti-diabetic medication, antihy-
pertensive medication, lipid-lowering medication, cannabis
misuse or abuse, alcohol misuse or abuse, tobacco use, poly-
pharmacy, obesity reported as comorbidity; (ii) Physical
health measures: glucose and lipids screening, blood pres-
sure measurement, weight measurement; (iii) Treatment
interventions during admission: evidence-based tobacco ces-
sation intervention, consultation of a dietician, cognitive
behavioural therapy initiated, social worker involved, occu-
pational therapy, family involvement e.g. family attendance
in psycho-education meetings, initiation of new anti-
psychotic medication. Family history of risk factors for car-
diovascular disease was not consistently recorded and could
therefore not be included. We collected the information
from the relevant subsections of patients’ files (e.g. glucose
screening from lab results) and notes from all involved pro-
fessionals such as nurses, psychologists, social workers, and
medical doctors.
Adverse events
AEs were defined as the negative unintended consequences
of clinical care that led to injury, impairment, or other
harm (Griffin & Resar, 2009; Kizer & Stegun, 2005).
Adverse drug reactions/event (ADRs) were defined as “a
negative, unintended consequence of a medication that
resulted in functional impairment or other significant harm”
(Marcus et al., 2017). An ADR was assumed to be present if
it matched one or more of three criteria: (A) an “always”
list of reactions or symptoms, such as (benign) elevated liver
enzymes; (B) medication stopped, held or additional medi-
cation was started due to an adverse reaction; and (C)
impaired basic functioning (e.g. standing, walking, seeing,
hearing, thinking, breathing) (Hermann, Marcus & Wiesel-
Cullen). The definitions of all adverse events have been
included as an appendix (Supplementary material) and
described elsewhere (Marcus et al., 2017).
We determined the percentage of admissions with one or
more AE, total number of AEs and the number of AEs per
1000 patient days. Furthermore, we determined the nature
of AEs and characteristics associated with the occurrence of
AE. Nine different types were distinguished (Supplementary
material): fall, self-harm or other injury to self, sexual con-
tact with other admitted patients, elopement, contraband on
unit, patient assault (victim or perpetrator), medication
error, adverse drug reaction and other non-drug patient
safety events.
We identified AEs from narrative text in the patient files
with the “Hospital Medical Record Data Collection Manual
of Patient Safety in Inpatient Psychiatry” tool, based on the
methodology of the Harvard Medical Practice Study
(Marcus et al., 2017). This tool, tested and in-depth
described in a previous study (Marcus et al., 2017), includes
nine predefined types of AEs, ranging from assaults to
ADRs (for an overview, see primary outcomes or
Supplementary material) (Brennan et al., 1991). The patient
files were reviewed in a two-stage method by three clinical
reviewers: two supervised master students screened all files
and the first author performed the final AE identification.
All reviewers had been trained in audio-recorded training
sessions presided by the creators of the tool (Hermann &
Wiesel). To this aim, the three reviewers individually
reviewed the same 20 training files and discussed the indi-
vidual results in consensus meetings. Subsequently, ten extra
training files were screened, after which the inter-rater reli-
ability among the two screeners was determined. This was
considered adequate (unweighted Cohen’s kappa was 0.69)
(Hanskamp-Sebregts et al., 2016). The second stage, the
actual identification of AEs from the patient files was con-
ducted by a physician [JMV]; if necessary a psychiatrist
[LdH] was consulted.
Statistical analysis
Characteristics of the study sample are presented as num-
bers and percentages for categorical data. Normally distrib-
uted continuous variables are presented as mean (standard
deviation) or median (interquartile ranges) in case of non-
normally distributed continuous variables. Process indicators
are presented as rates (number of patients that had a risk
factor, assessment or intervention divided by the total sam-
ple size). Frequencies and types of adverse events are listed
as countable frequencies and percentages. The incidence
density was calculated as the number of adverse events
occurring per 100 admissions and as the number of adverse
events per 1000 patient days. Characteristics of patients with
and without AEs were compared using the chi-square test
or Mann-Whitney test. A p-value of 0.05 (two-sided) was
considered statistically significant. All analyses were per-
formed in SPSS Statistics (IBM Corp, Armonk, NY, USA),
version 24.
Results
Study sample
We included data of 299 admissions of 237 unique patients
with a psychotic disorder. Fifty-eight percent of patients had
been diagnosed with schizophrenia (Table 1). The total
length of stay was11403 days; the median length of stay was
31 days (IQR 14-53).
Process indicators
Rates of process indicators are shown in Table 2. The most
frequent physical health risk factors were nicotine use (55%)
and cannabis abuse or misuse (28%). Physical health status
had been assessed in 75% of the patients whose laboratory
results had been documented and in 69% of the patients
whose weight measurements had been documented. One
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percent of patients who smoked had received an evidence-
based smoking-cessation intervention during admission.
Occupational therapy was the most frequent treatment
intervention (70%). The family was actively involved in 43%
of the cases.
Adverse events and associated characteristics
We found a total number of 235 AEs in 118 admissions, corre-
sponding to 21 AEs per 1000 patient days (Table 3). The highest
number of AEs recorded per admission was eight. One or more
AEs had been documented for 39% of all admissions. The fol-
lowing admission characteristics were associated with AEs:
length of stay (p< 0.001), compulsory admission (p¼ 0.037)
and seclusion during admission (p¼ 0.003) (Table 1).
Most of the AEs were adverse drug reactions (40%), fol-
lowed by elopement (17%) and assault (13%) (Table 2). The
antipsychotic medication was switched in 47%, the dose was
reduced in 18%, additional medication was started in 25%
and treatment remained unchanged in 10% of the adverse
drug reactions. One adverse drug reaction, classified as a
post-olanzapine injection syndrome, resulted in severe harm
(i.e. resuscitation with subsequently good outcome). Self-
harm (n¼ 4) was the least frequent AE. No falls, suicides or
suicide attempts had been documented.
Discussion
In this study, the quality of inpatient care for patients with
psychosis was evaluated by combining process and outcome
measures, expressed as adverse events. Strikingly, physical
health assessment was missing in one-third of the patients
and therewith potential treatment interventions could have
been missed. Although most patients smoked, only 1% of
smokers received an evidence-based smoking cessation
intervention. With respect to treatment interventions, in
only 43% of cases, the family was actively involved in the
treatment. Adverse drug reactions were the most frequent
type of adverse events in inpatients with psychosis and these
had been mainly induced by antipsychotic medication.
Process indicators
Regarding the performance on process indicators, a national
audit of schizophrenia patients in the UK showed, for example,
that physical health indicators were measured in 51% of the
patients having their BMI being assessed during the previous
12months (Crawford et al., 2014), compared to 69% our
patients. The UK sample consisted of both in- and outpatients,
which might perhaps explain the discrepancy with our find-
ings. The most plausible explanations for the unmeasured
physical risk indicators in the current study are that patients
refuse (parts of) the examination, that measurements are not
performed or that measurements are performed but not docu-
mented. Unfortunately, based on the available data, we cannot
distinguish between refused, not performed or not documented
physical examinations. Nevertheless, we believe that hospital-
ization is a window of opportunity to perform somatic screen-
ing – especially in severely mentally ill patients, given their
poor physical health, and their limited access to medical care
(De Hert, van Winkel, Silic, Van Eyck, & Peuskens, 2010).
Tobacco use is an undisputed risk factor for early death.
A previous study showed that adults with schizophrenia were
almost 10 (SMR 9.9, 95%CI 9.6–10.2) times as likely to die
from chronic obstructive pulmonary disease (COPD) than
Table 1. Study sample characteristics and associations with adverse events during admission (n¼ 299).
Variables With adverse event n¼ 118 (39%) No adverse event n¼ 181 (61%) p Value
Gender, male/female, n (%) 79 (66.9)/39 (33.1) 121(66.9)/60 (33.1) 0.99
Age, median (IQR) 33 (23–39) 30 (23–42) 0.85
Diagnosis, n (%) 0.64
Schizophrenia 67 (56.8) 105 (58.0)
Psychosis NOS 23 (19.5) 36 (19.9)
Schizophreniform 6 (5.1) 12 (6.6)
Schizoaffective 15 (12.7) 18 (9.9)
Bipolar with psychotic features 7 (5.9) 7 (3.9)
Other psychotic disordersa 0 3 (1.7)
Length of stay in days, median (IQR) 44 (27-66) 21 (10-43) <0.001
Compulsory admission, n (%) 68 (57.6) 81 (44.8) 0.04
Seclusion during admission, n (%) 22 (18.6) 13 (7.2) 0.003
aOther psychotic disorder can be specified as brief psychotic disorder and psychotic disorder due to medical condition.
NOS: Not otherwise specified; GAF: global assessment of functioning; IQR: interquartile range.
Significant findings are shown in bold.
Table 2. Rates of process indicators in admissions (n¼ 299).
Physical health risk factors Frequencies (%)
Tobacco use 55
Cannabis misuse or abuse 28
Alcohol misuse or abuse 8
Anti-diabetic medication 6
Polypharmacya 6
Obesity as comorbidity 6
Antihypertensive medication 5
Lipid lowering medication 2
Physical health measurements
Glucose and lipids screening 75
Blood pressure measurement 71
Weight
At least one measurement 69
(Range in kg) (37–137)
Treatment interventions during all admissions
Occupational therapy 70
Initiation of new antipsychotic medication 63
Family involvement 43
Social worker involved 25
Dietary consultation 10
CBT initiated 4
Tobacco cessation in smokers 1
kg: kilograms; CBT: cognitive behavioural therapy.
aPolypharmacy was defined by five or more medications.
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adults from the general population (Olfson et al., 2015). This
number should be a strong argument against the old-fashioned
view that treating tobacco addiction might not be one of the
priorities during the treatment of acute psychosis. We argue
that treating addiction to smoking is as important as recovery
from psychosis and that evidence-based cessation interventions
should be implemented into current care paths. There is sound
evidence on achievement of smoking cessation in individuals
with schizophrenia (Cather, Pachas, Cieslak, & Evins, 2017).
Implementation of treatment programs in combination with
smoke-free hospitals may eventually help to reverse the dra-
matic reduction in life span of patients with psychotic disorders
(Tiihonen et al., 2009). Our setting is unlikely to be an excep-
tion when it comes to the lack of support of patients who aim
to quit smoking in The Netherlands. Dutch psychiatric hospi-
tals often lack a clear policy regarding smoking (Blankers,
Buisman, ter Weijde, & van Laar, 2015). It would be valuable
to monitor whether implementation of stop smoking therapies
in patients in the form of nicotine replacement therapy, behav-
ioural support or pharmacotherapy is successful. Besides,
research showed that prohibiting smoking in psychiatric hospi-
tals was associated with reduced rates of aggression, which
might further motivate hospitals to change smoking guidelines
(Robson et al., 2017).
Finally, there is substantial evidence that active family
involvement improves the care for patients with psychosis,
for example with respect to adherence to antipsychotic
medication (Glick, Stekoll, & Hays, 2011). In the present
study, family was actively involved in 43% of cases. Previous
research found that the implementation of active family
involvement often falls behind due to the paradigm shift in
professionals from contact with to working with family
(Eassom, Giacco, Dirik, & Priebe, 2014). Although the early
psychosis unit in the current study organizes regular family
meetings and offers psychoeducation and training to the
family members of patients, the acute wards have not yet
implemented this and this could be a plausible explanation
for the relatively low numbers.
Adverse events
In this study, the occurrence of AEs (31 per 100 patient
discharges) was slightly higher than in a recent study
(28 per 100 patient discharges) in 40 acute psychiatric units
from medical centres in the national Veteran Health
Administration (VHA) system (Marcus et al., 2017). In the
present study, the occurrence of AEs was associated with
longer length of stay, seclusion during admission and com-
pulsory admissions were related with. Longer length of stay
and seclusion can also be a result of an AE, for example in
the case of assault. Prevention of AEs, especially in compul-
sorily admitted patients, could, therefore, result in a shorter
length of stay, and in turn, further reduce the occurrence of
AEs (Vermeulen et al., 2018).
Adverse drug reactions occurred more than twice as
often as any other AE. In many cases, these were caused by
antipsychotics use, but reactions varied, such from weight
gain, movement disorder to akathisia (Leucht et al., 2013).
A previous study on AEs during psychiatric hospitalizations
also found that adverse drug reaction was the most frequent
AE (Marcus et al., 2017). A reason for the high frequency of
adverse drug reactions might be the precarious balance
between efficacy and tolerability (Leucht et al., 2013). In our
opinion, adverse drug reactions caused by antipsychotics
must be systematically evaluated in every patient-physician
contact. The severity of an adverse reaction can be assessed
by instruments such as the Barnes Rating Scale for
Akathisia (Barnes, 1989), and if necessary, dosages should
be adjusted.
The limited number of AE to somatic medications is
somewhat surprising. We can only speculate why this
should be so: somatic medication might have been little
used or clinicians paid little attention to side-effects of som-
atic medication. The high frequency of elopements (17% of
all AEs) is mostly explained by patients returning substan-
tially later than agreed or not returning from temporary
leave. As these events might endanger the safety of the
patient and its environment, these were also scored as an
AE. Temporary leave is included in the treatment program
as a means of regaining autonomy but it is subject to the
risk of harm. Lastly, interventions aimed to reduce aggres-
sive behaviour that may lead to assault form an important
quality improvement area. There are several interesting
developments in the field, such as Safewards, which is a
randomized controlled trial was found effective in reducing
harmful situations (Bowers et al., 2015).
Table 3. Types and frequencies of adverse events (n¼ 235).
Type of adverse event n (%) n per 100 admissions n per 1000 patient days
1. Adverse drug reactions of which: 93 (40) 31 8
Induced by SGA 50
Induced by FGA 41
Induced by other medicationa 2
2. Patient elopement 40 (17) 13 4
3. Assault 31 (13) 10 3
4. Medication error 27 (11) 9 2
5. Contraband on unit 26 (11) 9 2
6. Other patient safety eventsb 9 (4) 3 <1
7. Sexual contact 5 (2) 2 <1
8. Self-harm or injury to self 4 (2) 1 <1
9. Patient fall 0 0 0
Total 235 (100) 79 21
SGA: second generation antipsychotic; FGA: first generation antipsychotic.
aOther medication¼mood stabilizer and somatic medication.
bPatient readmission within three days or not allowed smoking at wards.
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Research findings and implications
Despite the efforts of international committees to introduce
the valid and reliable process and outcome measures
(Addington et al., 2012; Hermann et al., 2002), improve-
ment of the quality of care for psychotic patients so far is
hindered by the lack of data (Pincus, 2010). A Cochrane
review from 2012 showed that an audit of performance indi-
cators and feedback of this data to care providers can
improve quality of care (Ivers et al., 2012). The feedback to
providers maybe even more effective when: baseline per-
formance of providers is low, the source of feedback is a
supervisor or a colleague, feedback is provided more than
once both in verbal and written formats and when it
includes explicit targets and an action plan (Ivers et al.,
2012). Quality outcomes may well serve to improve care
paths – with for example “Plan Do Study Act-cycles”
(PDSA) (Etchells, Ho, & Shojania, 2015). A PDSA-cycle can
guide quick improvement of a quality gap, also when work-
ing with small sample sizes (Etchells et al., 2015). Based on
the results of an audit, patients and professionals should pri-
oritize together which areas need the first focus for
improvement. Our study shows that retrospective data col-
lection from electronic medical records can be used to audit
process and outcome measures without an additional bur-
den to patients or clinicians; it provides easily interpretable
results and does not intervene with the care process. On the
other hand, this approach is labor-intensive as long as
machine-learning strategies to identify events, such as a tool
that identifies extrapyramidal side effects, are not yet used
(Iqbal et al., 2015). Future qualitative research is needed to
triangulate the views of health care professionals and
patients regarding explanations and how to improve meas-
urement of clinically important process and out-
come indicators.
Limitations
The results of the current study should be interpreted in
light of the following limitations. First, the retrospective
design could have induced measurement error. Recall bias
may have influenced the results since clinicians could have
omitted to report AEs, risk assessment or treatment inter-
ventions. Consequently, frequencies might have been under-
estimated. Still, tools that use predefined outcome measures
to identify AEs retrospectively as used in the current study
yield at least ten times more AEs than a conservative
method like voluntary reporting (Classen et al., 2011).
Nevertheless, using standardized medical records that
address clinically meaningful processes of care could
improve data collection. Second, although the inter-rater-
reliability was adequate, differences in assigning AEs or pro-
cess indicators may have influenced the results. Third, we
chose to measure process and outcome indicators (e.g. AEs)
over the limited period of a patient’s admission. As recom-
mended by the Organization for Economic and Community
Development’s Health Care Quality Indicators Project
(OECD-HCQI), inclusion of additional long-term outcome
indicators such as mortality and re-admission after inpatient
care is preferred (Hermann et al., 2006). Fourth, we assumed
that a test or intervention had not taken place if it was not
documented (Crawford et al., 2014). However, patients with
psychosis might suffer from a lack of illness insight and there-
fore might have refused assessments. As mentioned earlier,
we could not distinguish between refusal and missed assess-
ments. Fifth, we included chronic and first episode patients
but did not distinguish differences between these groups
because data were lacking, whilst chronic patients are more
likely to suffer from health issues. Sixth, social factors such as
unemployment or isolation could influence patients’ out-
comes but have not been measured in this study. It could be
valuable to incorporate this in future studies into this topic.
Lastly, generalizability is limited because this was a single
centre study. Particular characteristics, such as being allowed
to smoke in designated areas, hinder the comparison with
smoke-free hospitals in other countries.
Conclusions
In conclusion, this study is novel in that it presents data on
the quality of processes and outcomes derived from medical
records of psychotic patients, which can provide a solid base
to start improving care. Having applied this approach, we
conclude that patients diagnosed with schizophrenia or
other psychotic disorders are prone to adverse events and
especially to adverse drug reactions. High-quality care is
needed because patients with psychosis frequently have som-
atic comorbidities and a huge excess of mortality. The over-
arching goal of measuring quality is improvement of care –
and collecting quality data is an important means to achieve
this. Future studies should focus on interventions to
improve the care and outcomes of patients with psychosis.
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